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Abstract ArfA rescues ribosomes stalled on truncated mRNAs by recruiting release factor RF2,
which normally binds stop codons to catalyze peptide release. We report two 3.2 A˚ resolution cryo-
EM structures – determined from a single sample – of the 70S ribosome with ArfA.RF2 in the A
site. In both states, the ArfA C-terminus occupies the mRNA tunnel downstream of the A site. One
state contains a compact inactive RF2 conformation. Ordering of the ArfA N-terminus in the second
state rearranges RF2 into an extended conformation that docks the catalytic GGQ motif into the
peptidyl-transferase center. Our work thus reveals the structural dynamics of ribosome rescue. The
structures demonstrate how ArfA ‘senses’ the vacant mRNA tunnel and activates RF2 to mediate
peptide release without a stop codon, allowing stalled ribosomes to be recycled.
DOI: 10.7554/eLife.23687.001
Introduction
A translating ribosome stalls when it encounters the end of a non-stop mRNA, truncated during cel-
lular stress or homeostasis, by premature transcription termination or mRNA cleavage or other
mechanisms (Hayes and Keiler, 2010; Keiler, 2015). The stalled ribosome contains peptidyl-tRNA
in the P site, whereas the aminoacyl-tRNA (A) site is unoccupied (Ito et al., 2011). Bacteria have
evolved ribosome-rescue pathways to release the nascent peptide and re-enable the stalled ribo-
some for translation (for a review, see ref. [Keiler, 2015]). The ArfA (alternative rescue factor A)
pathway is essential in trans-translation-deficient cells (Chadani et al., 2010) and is thought to func-
tion as a backup mechanism for trans-translation in enterobacteria (Garza-Sa´nchez et al., 2011;
Chadani et al., 2011; Schaub et al., 2012). ArfA is a small protein (~70 aa in most organisms), with
only 47 amino acids sufficient for function, as shown for E. coli ArfA truncations (Garza-
Sa´nchez et al., 2011). ArfA recruits release factor RF2 to rescue stalled ribosomes (Chadani et al.,
2012; Shimizu, 2012). RF2 normally mediates translation termination at UGA or UAA stop codons
by binding the stop codon and catalyzing peptidyl-tRNA hydrolysis and release of the nascent pep-
tide (Craigen and Caskey, 1987; Korostelev, 2011). RF2 has remarkable specificity toward stop
codons (Freistroffer et al., 2000) and does not function alone on truncated mRNA (Chadani et al.,
2012; Shimizu, 2012). In this work, we asked how ArfA and RF2 sense the stalled ribosome, and
how ArfA aids RF2 to catalyze peptide release in the absence of a stop codon.
To better understand ribosome rescue by ArfA and RF2, we formed an E. coli 70S ribosome res-
cue complex with mRNA truncated after an AUG codon in the P site, tRNAfMet, ArfA and RF2, and
captured images of complexes by electron cryo-microscopy (cryo-EM; see Materials and methods).
Unsupervised classification of a single cryo-EM dataset (Figure 1—figure supplement 1) using
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FREALIGN (Grigorieff, 2016) revealed two ribosome structures with both ArfA and RF2 bound in
the A site (Structures I and II; Figure 1 and Figure 1—figure supplement 2 and Table 1). Structure I
contains a compact RF2 (Figure 1A and C) and is represented by ~26% of ribosome particles in the
cryo-EM dataset. Structure II contains an extended RF2 (Figure 1B and D; ~18% of ribosomes). Both
structures contain tRNAs in the P and E (exit) sites and adopt a non-rotated conformation
(Yusupov et al., 2001; Korostelev et al., 2006; Selmer et al., 2006), similar to that in translation
termination complexes (Korostelev et al., 2008; Laurberg et al., 2008; Weixlbaumer et al., 2008).
High-resolution maps (Figure 1E and F and Figure 1—figure supplements 3–5) allowed de novo
modeling of ArfA (Figure 1E and Figure 1—figure supplement 3) and detailed structure determina-
tion of RF2 (Figure 1E and F and Figure 1—figure supplement 4) in each ribosome structure. The
molecular interactions and conformational rearrangements inferred from Structures I and II provide
the structural basis for ArfA-mediated ribosome rescue, as described below.
Results and discussion
ArfA C-terminus occupies the mRNA tunnel to sense the stalled
ribosome
Sequence alignment of several hundreds of bacterial ArfA homologs reveals conserved hydrophobic
N-terminal and positively charged C-terminal regions (Figure 2). The high conservation of these
regions implicates their functions in protein and RNA interactions, respectively. In Structures I and II,
the conformations of the N-terminal region differ as described in the following sections, but the rest
of ArfA is similar. The mid-region of ArfA (His21 to Glu30; E. coli numbering is used) lies in the A site
(Figure 1C and D). ArfA leaves a ~12 A˚ gap in the codon-binding region, sufficient to accommodate
one or two nucleotides of mRNA following the P-site codon but not a longer mRNA, consistent with
the reduced efficiency of ArfA-mediated release on mRNAs that extend three or more nucleotides
beyond the P site (Shimizu, 2012; Zeng and Jin, 2016).
The C-terminal region of ArfA occupies the mRNA tunnel between the head and body of the 30S
subunit (Figure 2—figure supplements 1A and 2), as suggested by previous hydroxyl-radical prob-
ing studies (Kurita et al., 2014). The mRNA tunnel is primarily formed by the negatively charged
16S rRNA backbone. ArfA is stabilized by electrostatic interactions, as positively charged amino
acids comprise nearly half of the ArfA residues within the mRNA tunnel (aa 31–48; Figure 2B). ArfA
residues Lys44 to Arg48 approach the mRNA tunnel entry at the solvent side of the 30S subunit,
formed by 16S rRNA and proteins S3, S4 and S5 (Figure 2 and Figure 2—figure supplement 1A).
Consistent with ArfA structure prediction (Kim et al., 2004; Yang et al., 2015), the tail of ArfA
appears to form a short a-helix (aa ~50–55) next to S5; however, the resolution of the map is not suf-
ficient to build an unambiguous structural model (Figure 2—figure supplement 2). This suggests
conformational disorder of the C-terminus at the entrance to the mRNA tunnel. Our structures are
consistent with biochemical studies (Chadani et al., 2011), which showed that ArfA is functional with
a C-terminal truncation at Asn47, but further shortening inactivates ArfA. In particular, truncations
following Met40—removing at least five basic amino acids that bind in the tunnel—abrogate ArfA-
mediated release by reducing ArfA affinity for the 70S ribosome (Chadani et al., 2011).
We compared ArfA with proteins ArfB (also known as YaeJ; [Gagnon et al., 2012]) and SmpB
(Neubauer et al., 2012; Ramrath et al., 2012), which mediate alternative rescue pathways
(reviewed in [Keiler, 2015]). In ArfB-mediated release and SmpB-mediated trans-translation, the pro-
teins sense the stalled ribosomes by occupying the mRNA tunnel (Gagnon et al., 2012;
Neubauer et al., 2012). Consistent with sequence divergence among the C-termini of ArfA, ArfB,
and SmpB, however, each interacts with the mRNA tunnel differently. ArfB performs peptide release
when its C-terminus forms a long a-helix in the tunnel (Gagnon et al., 2012). SmpB bound with
tmRNA in preparation for trans-translation, forms a shorter a-helix, well-resolved near the mRNA
entry at the 30S solvent surface (Neubauer et al., 2012). SmpB is similar to ArfA in that both pro-
teins are sensitive to the mRNA occupancy of the A site (Ivanova et al., 2004; Shimizu, 2012;
Zeng and Jin, 2016), whereas ArfB can function on stalled ribosomes with either the vacant or occu-
pied A site (Handa et al., 2011). Diverged sequences, structures and binding modes of these pro-
teins likely reflect distinct affinities and sensitivities to stress conditions, in keeping with their roles in
mediating distinct ribosome rescue pathways (Figure 2—figure supplement 1).
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Figure 1. 3.2 A˚ resolution cryo-EM structures of E. coli 70S ribosome bound with ArfA and release factor RF2. (A) Structure I with RF2 in a compact
conformation; (B) Structure II with RF2 in an extended conformation. Domains 2 and 3 and the GGQ motif of RF2 are labeled. (C) and (D) A close-up
view down the mRNA tunnel, showing RF2 and ArfA in the A site of Structure I (C) and Structure II (D). The body and head domains of the 30S subunit
are labeled. (E) Extended b-sheet formed by ArfA (red model) and RF2 (blue model). Cryo-EM map (gray mesh) is shown for Structure II at s = 2.5. (F)
Figure 1 continued on next page
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ArfA N-terminus is disordered in the presence of a compact (inactive)
RF2 conformation
In Structure I, only the central and C-terminal parts of ArfA are visible, indicating that the N-terminal
region (aa 2–16) is disordered. RF2 adopts a compact conformation (Figure 3A) similar to that of
free (ribosome-unbound) RF2 observed in crystal structures (Figure 3B) (Vestergaard et al., 2001;
Zolda´k et al., 2007). By contrast, in canonical termination complexes formed on stop codons,
release factors have only been observed in an extended (open) conformation (Korostelev et al.,
2008; Weixlbaumer et al., 2008). During translation termination, codon-recognition determinants
in domain 2 (including the conserved 205SPF207 motif) of RF2 bind the stop codon in the A site of the
30S subunit. Helix a7 of domain 3 bridges the ribosomal subunits, placing the catalytic GGQ motif
of domain 3 within the peptidyl-transferase center of the 50S subunit (Korostelev et al., 2008;
Weixlbaumer et al., 2008). In the ArfA-bound Structure I, however, helix a7 packs on the b-sheet of
domain 2 near the 30S subunit (Figure 3A and B). In this compact conformation, the loop that con-
tains the 250GGQ252 motif of RF2 lies to the side of the b-sheet (near aa 165–168) of domain 2, fac-
ing the anticodon-stem loop and the D stem of the P-site tRNA. As such, the GGQ motif is roughly
70 A˚ away from its catalytically engaged position within the peptidyl-transferase center (Figure 3C
and D). Poor resolution of the catalytic GGQ residues (Figure 1—figure supplement 4A) at the tip
of the loop suggests local structural flexibility, similar to that seen in crystal structures of free release
factors (Vestergaard et al., 2001; Shin et al., 2004; Zolda´k et al., 2007).
The codon-recognition domain 2 of RF2 is positioned differently from that in canonical termina-
tion complexes. The domain is withdrawn from the A site, such that the SPF motif and other codon-
recognition residues lie ~5 A˚ away from their positions in termination complexes bound to a stop
codon (Figure 4 and Figure 1—figure supplement 4A). This position results from the mid-region of
ArfA being sandwiched between domain 2 of RF2 and the decoding center. Here, the backbone of
ArfA residues 25–29 binds to RF2 residues 213–217 within the b-sheet of domain 2 (Figure 1E),
forming an extended b-sheet platform (Figure 4A and D). The conformation of the decoding center
in Structure I differs from that in canonical termination complexes. In 70S termination complexes,
the decoding center interacts with the switch loop of RF2 (aa 315–323), which bridges the codon-
recognition and catalytic domains (Korostelev et al., 2008; Weixlbaumer et al., 2008). A1492
bulges from helix 44 (h44) of 16S rRNA and stacks on conserved Trp319 of the switch loop
(Figure 4C), stabilizing the extended conformation of RF2 on the ribosome (Figure 4F)
(Korostelev et al., 2008; Weixlbaumer et al., 2008). In Structure I, however, A1492 and A1493 lie
inside h44 and are sandwiched between Pro23 of ArfA and A1913 of helix 69 of 23S rRNA
(Figure 4A). The RF2 switch loop is poorly ordered. Putative density suggests that Trp319 is
placed >10 A˚ away from its position in the termination complex and does not contact the decoding-
center nucleotides (Figure 4D and Figure 1—figure supplement 4A).
Figure 1 continued
Peptidyl-transferase center bound with the 250GGQ252 motif of RF2 in Structure II. Cryo-EM map (gray mesh) is shown at s = 2.5 for RF2 and at s = 4.5
for 23S ribosomal RNA and the 74CCA76 end of the P-site tRNA. The maps were sharpened by applying the B-factor of  120 A˚2. Additional views of
cryo-EM density are available in Figure 1—figure supplements 1–5. In all panels, the large 50S ribosomal subunit is shown in gray/light-blue; the small
30S subunit in yellow; mRNA in green; E-site tRNA in magenta; P-site tRNA in orange; ArfA in red and RF2 in blue.
DOI: 10.7554/eLife.23687.002
The following figure supplements are available for figure 1:
Figure supplement 1. Schematic of cryo-EM refinement and classification.
DOI: 10.7554/eLife.23687.003
Figure supplement 2. Cryo-EM densities of Structures I and II.
DOI: 10.7554/eLife.23687.004
Figure supplement 3. Cryo-EM densities corresponding to N- and C-terminal regions of ArfA in Structures I and II.
DOI: 10.7554/eLife.23687.005
Figure supplement 4. Cryo-EM densities corresponding to functional regions of RF2 in Structures I and II.
DOI: 10.7554/eLife.23687.006
Figure supplement 5. Cryo-EM densities of ribosomal RNA in Structure II.
DOI: 10.7554/eLife.23687.007
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Table 1. Cryo-EM data collection and refinement statistics.
Structure I Structure II
PDB code 5U9G 5U9F
EMDB code EMD-8522 EMD-8521
Data collection
EM equipment FEI Titan Krios FEI Titan Krios
Voltage (kV) 300 300
Detector DE-20 DE-20
Pixel size (A˚) 1.215 1.215
Electron dose (e-/A˚2) 61 (used 30) 61 (used 30)
Defocus range (mm)  0.5 to  3.0  0.5 to  3.0
Reconstruction
Software Frealign v9.10–9.11 Frealign v9.10–9.11
Number of particles used 139,861 96,070







Non-hydrogen atoms 152671 152841
Protein residues 6561 6576
RNA bases 4729 4729
Ligands (Zn2+/Mg2+) 1/348 1/360
Refinement




R-factor (RSRef) 0.187 0.194
Validation (proteins)
MolProbity score 2.3 2.2
Clash score, all atoms 12.6 13.0
Good rotamers (%) 93.7 94.4
Ramachandran-plot
statistics (%)
Favored (overall) 88.4 88.2
Allowed (overall) 10.6 10.8
Outlier (overall) 1.0 1.0
Favored (ArfA) 86.7 88.9
Allowed (ArfA) 13.3 11.1
Outlier (ArfA) - -
Favored (RF2) 86.4 92.5
Allowed (RF2) 13.6 7.2
Outlier (RF2) - 0.3
R.m.s. deviations
Bond length (A˚) 0.006 0.005
Bond angle (˚) 0.852 0.864
Table 1 continued on next page
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Taken together, Structure I describes a 70S rescue complex in which ArfA stabilizes a compact
form of RF2 resembling that of free RF2. The remote position of RF2’s catalytic GGQ motif—away
from the peptidyl-transferase center—indicates that Structure I represents an inactive form of the
70S rescue complex.
The ordering of the ArfA N-terminus is coupled with an extended
(active) RF2 conformation
Structure II features an extended conformation of RF2 (Figures 1B, 3C and D), stabilized by interac-
tions with the ordered N-terminal region of ArfA (Figures 2, 4B and E). The N-terminus of ArfA
forms a minidomain, which packs between helix 69 of 23S rRNA, the b-sheet of domain 2, and
Table 1 continued
Structure I Structure II
Validation (RNA)





Figure 2. Structure and sequence of ArfA. (A) Close-up view of the intersubunit space and mRNA tunnel occupied by ArfA in Structure II. The color-
coding is the same as in Figure 1. The head and body domains of the 30S subunit are labeled. (B) Sequence and structure of ArfA, shown in the same
orientation as in (A). Sequence conservation among ~400 non-redundant bacterial ArfA homologs is shown for four ArfA regions (see Materials and
methods). The color code for amino acid type in the sequence logo is the following: green – polar, purple – neutral, blue – basic, red – acidic and black
– hydrophobic residues.
DOI: 10.7554/eLife.23687.009
The following figure supplements are available for figure 2:
Figure supplement 1. Comparison of mRNA tunnel occupancies by ribosome rescue proteins ArfA, ArfB and SmpB (shown in red).
DOI: 10.7554/eLife.23687.010
Figure supplement 2. Putative a-helical structure of the C-terminal region of ArfA at the entry of the mRNA tunnel (near protein S5) in Structures I and
II (Structure II is shown).
DOI: 10.7554/eLife.23687.011
Figure supplement 3. Structure of the N-terminal tail of ArfA near the decoding center in Structure II.
DOI: 10.7554/eLife.23687.012
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extended helix a7 of RF2 (Figure 2—figure supplement 3). The tip of the ArfA minidomain (at aa
12–13) protrudes from the decoding center toward the 50S subunit, whereas the N-terminus folds
back toward the decoding center, consistent with recent hydroxyl-radical probing studies
(Kurita et al., 2014). Here, Thr7 and Lys8 bind h44 (at A1410) of 16S rRNA and the N-terminal
amino acids bind the b-sheet of S12 (Figure 2—figure supplement 3).
A hydrophobic patch in the N-terminal minidomain of ArfA (Figure 2B) — formed by Leu19,
Leu24, and Phe25—binds RF2 at Trp319 of the rearranged switch loop (Figure 4B and E and
Figure 3. RF2 adopts two distinct conformations in Structures I and II. (A) The P and A sites of Structure I. ArfA is shown in red; RF2 in blue; mRNA in
green; P-tRNA in orange; 30S subunit in yellow; and 50S subunit in light blue. (B) Superposition of RF2 from Structure I (blue) with the crystal structure
of free (ribosome-unbound) E. coli RF2 (PDB 1GQE) (pink). Relative positions of the codon-recognition superdomain (domains 2 and 4) and catalytic
domain 3 are nearly identical. The positions of domain 1 differ; this domain in both Structures I and II interacts with the L11 stalk at the 50S subunit
shown in panels (A), (C) and (F). (C) The P and A sites of Structure II. The color coding is as in panel (A). (D) Superposition of extended RF2 in Structure
II (blue) with Thermus thermophilus RF2 in the canonical termination complex formed on the UAA stop codon (PDB 4V67) (pink). The superposition was
performed by structural alignment of 16S ribosomal RNAs. RF2 adopts similar conformations but domains 2 and 3 are positioned slightly differently
with respect to the 30S subunit in the rescue complex II and in the termination complex (see also Figure 4). (E) Superposition of RF2 in Structures I
(blue) and II (cyan), achieved by structural alignment of the 16S ribosomal RNAs. Conformations of RF2 and positions relative to the 30S subunit differ
between Structures I and II, as RF2 in Structure II binds deeper in the A site; differences in positions of RF2 regions are labeled with arrows. (F) Different
positions of the L11 stalk, which interacts with domain 1 of RF2, in Structures I (light blue) and II (cyan), suggesting movement of the stalk together with
domain 1 (E) upon RF2 activation. The view is similar to that shown in panels A, C and E. In panels (B), (D) and (E), the Arabic numerals label the
domains of RF2.
DOI: 10.7554/eLife.23687.013
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Figure 1—figure supplement 4B). These interactions explain the strict dependence of ArfA on RF2,
rather than on the second release factor RF1 (Chadani et al., 2012; Shimizu, 2012), whose switch
loop is diverged from that of RF2 and lacks tryptophan (Korostelev et al., 2010). The hydrophobic
patch in the N-terminal minidomain also binds RF2 at Val198 and Phe217 of the b-sheet of the
codon-recognition domain 2 (Figure 4B and E and Figure 1—figure supplement 4B). In this
Figure 4. Positions of the codon-recognition domain (blue) and switch loop (yellow-green) of RF2 in Structures I and II (this work) and in the translation
termination complex formed on the UAA stop codon (Korostelev et al., 2008). (A–C) Detailed view of the decoding center of Structure I (A), Structure
II (B), and canonical termination complex formed on the UAA stop codon (C). (D–F) 90-degree rotated views (relative to those shown in panels A–C) of
the decoding center in Structure I (D), Structure II (E) and the UAA-containing termination complex (F). The switch loop of RF2, which carries the
conserved Trp319, adopts different positions in these three structures. Key structural features and residues of ArfA, RF2, mRNA stop codon and the
ribosomal decoding center are labeled. ArfA is shown in red; RF2 in blue (RF2 switch loop in yellow-green); mRNA in green; 30S nucleotides in yellow;
and 50S nucleotides in light blue.
DOI: 10.7554/eLife.23687.014
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configuration, the codon-recognition domain of RF2 partially settles into the decoding center, but
remains ~3 A˚ from its position in canonical termination complexes bound to a stop codon. As in
Structure I, the SPF motif remains unbound to the ribosome or ArfA. This observation explains why
mutation of SPF motif residues—critical for stop-codon recognition—do not disrupt ArfA-mediated
peptide release (Chadani et al., 2012).
The position of the ArfA N-terminal minidomain between RF2’s domain 2 and helix a7 of domain
3 results in docking of domain 3 into the peptidyl-transferase center (Figures 1, 3C and D). The
opening of domain 3 is accompanied by movement of domain 1 of RF2 (Figure 3E), which binds the
L11 stalk and shifts the L11 stalk by ~7 A˚ toward the A site, relative to that in Structure I (Figure 3F).
The coordinated shift of L11 and domain 1 likely contribute to the movement of domain 3 toward
the PTC, echoing the involvement of the L11 stalk in canonical termination by RF2 (Xu et al., 2002;
Sato et al., 2006). The catalytic GGQ motif of domain 3 binds in the peptidyl-transferase center
with the catalytic backbone amide of Gln252 (Korostelev et al., 2008; Santos et al., 2013) proximal
to the ribose of the terminal A76 of P-site tRNA (Figure 1F, Figure 1—figure supplement 4B). The
conformation of the peptidyl-transferase center is nearly identical to that seen in canonical transla-
tion termination complexes (Korostelev et al., 2008; Weixlbaumer et al., 2008). Structure II there-
fore represents an activated state of the ArfA.RF2-bound ribosome rescue complex.
Structures I and II are in agreement with previous biochemical and mutagenesis studies, as we
have described above (Chadani et al., 2010, 2012; Shimizu, 2012; Kurita et al., 2014; Zeng and
Jin, 2016). An ArfA-inactivating mutation has been identified (Chadani et al., 2010). Mutation of
Ala18 of the N-terminal ArfA minidomain to threonine prevents ArfA-mediated peptide release with-
out disrupting RF2 binding (Shimizu, 2012). In Structure II, Ala18 lies in the hydrophobic core of the
N-terminal fold, tightly packed between the nucleobase of C1914 of h69 and Ile11 of ArfA (Fig-
ure 2—figure supplement 3). The substitution to the larger threonine residue is likely incompatible
with the ordered N-terminal fold of ArfA and the extended conformation of RF2. The mutation
should, however, be compatible with an inactive ribosome rescue complex (Structure I), consistent
with RF2 binding and the lack of catalytic activity.
Structural mechanism of ribosome rescue by ArfA and RF2
During ribosome rescue, the release of the nascent peptide should strictly coordinate with the rec-
ognition of a vacant mRNA tunnel. Our cryo-EM analysis indicates that ribosomes formed on a trun-
cated mRNA in the presence of ArfA and RF2 adopt at least three states, including Structures I, II
and the ribosome with a vacant A site (Figure 1—figure supplement 1). These states suggest a
structure-based model for stepwise release of nascent peptides from stalled ribosomes during ArfA-
mediated ribosome rescue (Figure 5), summarized as an animation (Video 1, also available at http://
labs.umassmed.edu/korostelevlab/movarfa.gif).
In the absence of an A-site codon, peptidyl-tRNA-bound ribosomes cannot bind aminoacyl-tRNA
(Figure 5A). They are recognized by ArfA, which binds the empty mRNA tunnel and recruits a com-
pact (inactive) conformation of RF2 (Figure 5B). Biochemical studies showed that ArfA can bind the
ribosome without RF2 (Kurita et al., 2014), suggesting that ArfA precedes RF2. We do not observe
ribosomes bound with ArfA alone. This indicates that ArfA has a substantially higher affinity in the
presence of RF2 and predominantly binds as a complex with RF2. Additional biochemical studies are
required to elucidate this step. The initial rescue complex (Structure I) then samples an extended
(active) conformation of RF2 coupled to ordering of the N-terminal minidomain of ArfA at the ribo-
somal decoding center (Structure II; Figure 5C). Although such structural rearrangement of release
factors RF1 and RF2 has not been directly observed during canonical termination, it has been sug-
gested based on structural comparisons (Rawat et al., 2003; Laurberg et al., 2008) and biochemi-
cal studies that revealed dynamic behaviors of domain 3 and the switch loop (He and Green 2010;
Trappl and Joseph, 2016). A low-resolution small-angle X-ray scattering study proposed a predomi-
nant extended conformation of free E. coli RF1 (Vestergaard et al., 2005). However, subsequent
characterization of E. coli and Thermus thermophilus RF2 (Zolda´k et al., 2007) and E. coli RF1
(Trappl and Joseph, 2016) demonstrated predominance of the closed form in solution, consistent
with crystal structures of RF2 and RF1 (Vestergaard et al., 2001; Shin et al., 2004; Zolda´k et al.,
2007). The tmFRET study that followed changes in inter-domain distances in RF1, found that the
pre-termination ribosome initially interacts with a closed form of RF1 and induces a large-scale
Demo et al. eLife 2017;6:e23687. DOI: 10.7554/eLife.23687 9 of 18
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rearrangement (Trappl and Joseph, 2016). The
opening of a release factor is therefore a plausi-
ble conserved mechanism to separate the
‘decoding’ and ‘catalytic’ functions of release
factors.
In the 70S.ArfA.RF2 complex, the opening of
RF2 places the GGQ motif into the peptidyl-
transferase center (Structure II), where it cata-
lyzes peptidyl-tRNA hydrolysis, releasing the
nascent peptide from the ribosome (Figure 5C).
Dissociation of ArfA and RF2, possibly through
the inactive Structure I state (Figure 5D), results
in ribosomes with a vacant A site and deacylated
tRNA in the P site, enabling subsequent recy-
cling of the ribosome.
After submission of this manuscript, several
other structures of 70S.ArfA.RF2 complexes with
RF2 in the extended conformation were
reported (James et al., 2016; Huter et al.,
2017; Ma et al., 2017; Zeng et al., 2017). Struc-
ture I, however, was not found in these studies.
A compact conformation of RF2, similar to that
in Structure I, was observed in the presence of a
heterologous ArfA.RF2 system or the ArfA A18T
mutant (James et al., 2016). The observation of
both the compact and extended RF2 conforma-
tions in a single dataset in our work could be the
result of different conditions of complex prepa-
ration and/or data processing and classification
(see Materials and methods). In summary, the
reported structures closely agree with our find-
ings and are consistent with the proposed mech-
anism of ribosome rescue.
The mechanism of ArfA-mediated ribosome
rescue is remarkably different from canonical
Figure 5. Mechanism of ArfA-mediated rescue of ribosomes stalled on truncated mRNA. (A–B). ArfA senses the
stalled ribosome by binding its C-terminal portion in the vacant mRNA tunnel, recruiting RF2 in an inactive
conformation (as in Structure I). (C) Folding of the N-terminal minidomain of ArfA is coupled with the opening of
RF2, placing the GGQ motif into the peptidyl-transferase center (as in Structure II) and catalyzing peptidyl-tRNA
hydrolysis. (D) Following peptide release, ArfA and RF2 (likely in a compact conformation) depart, preparing the
ribosome for recycling.
DOI: 10.7554/eLife.23687.015
Video 1. An animation showing structural transitions
during ArfA-mediated ribosome rescue. Four scenes
are shown: (1) A view of the complete 70S complex, as
in Figure 1A and B. The stalled ribosome with a
truncated mRNA and a vacant A site, identified in our
cryo-EM sample (Figure 1—figure supplement 1) is
followed by Structure I and Structure II. (2) The opening
of RF2, from Structure I to II, coupled with the
movement of the L11 stalk. The transition between
Structure I and Structure II was generated using the
UCSF Chimera ‘Morph Conformations’ tool. (3) A close-
up view of the decoding center, showing the
rearrangements of ribosomal nucleotides, ArfA and
RF2, coupled with the opening of domain 3 of RF2. (4)
A proposed mechanism of ribosome rescue by ArfA
and RF2, schematically shown in Figure 5. The
animation is also available at http://labs.umassmed.
edu/korostelevlab/movarfa.gif
DOI: 10.7554/eLife.23687.016
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translation termination, wherein RF2 accurately defines the lengths of cellular proteins by direct rec-
ognition of stop codons in the A site (Korostelev et al., 2008; Weixlbaumer et al., 2008). While
ArfA converts RF2 into a stop-codon-independent release factor, our structures show that: (i) ArfA
does not mimic a stop codon; (ii) the conserved codon-recognition elements of RF2—including the
SPF motif—are not required (Chadani et al., 2012); and (iii) instead of interacting directly with RF2,
the ribosomal decoding center stabilizes ArfA, which in turn stabilizes an active RF2 conformation.
Thus, bacteria have evolved an intricate stress-response mechanism in which a small protein with
specific affinity to the stalled ribosome re-purposes a release factor. The ArfA-mediated ribosome
rescue highlights an impressive ability of living organisms to co-opt existing cellular mechanisms for
different and sometimes mutually exclusive purposes.
Materials and methods
Preparation of ArfA and RF2
The gene encoding E. coli ArfA (ASKA Clone(-) library, National BioResource Project, NIG, Japan)
was subcloned into pET24b+ (Novagen) kanamycin resistance vector using the primer set CCCGCA-
TATGCATCACCATCACCATCACATGAGTCGATATCAGCATACTAAAGGGC/CCCGGGATCCGTGA
TTTACTTTCTTGCCAC containing the NdeI/BamHI restriction sites (underlined) and transformed
into an E. coli BLR/DE3 strain. The resulting ArfA protein is 60 amino acids long and is N-terminally
His6-tagged. DNA sequencing confirmed the native sequence of the ArfA gene. Cells containing the
pET24b+ plasmid were cultured in Luria-Bertani (LB) medium with 50 mg mL 1 kanamycin at 37˚C
until the OD600 reached 0.7–0.8. Expression of ArfA was induced by 1 mM IPTG (Gold Biotechnology
Inc., USA), followed by cell growth for 9 hr at 16˚C. The cells were harvested, washed and resus-
pended in buffer A (50 mM Tris-HCl (pH 7.5), 150 mM KCl, 10 mM imidazole, 6 mM b-mercaptoe-
thanol (bME) and protease inhibitor (complete Mini, EDTA-free protease inhibitor tablets, Sigma
Aldrich, USA). The cells were disrupted with a microfluidizer (Microfluidics, USA), and the soluble
fraction was collected by centrifugation at 18,000 rpm for 20 min and filtered through a 0.22 mm
pore size sterile filter (CELLTREAT Scientific Products, USA).
ArfA was purified in three steps. The purity of the protein after each step was verified by 12%
SDS-PAGE stained with Coomassie Brilliant Blue R 250 (Sigma-Aldrich). First, affinity chromatogra-
phy with Ni-NTA column (Nickel-nitrilotriacetic acid, 5 ml HisTrap, GE Healthcare) was performed
using FPLC (A¨kta explorer, GE Healthcare). The cytoplasmic fraction was loaded onto the column
equilibrated with buffer A and washed with the same buffer. ArfA was eluted with a linear gradient
of buffer B (buffer A with 0.5 M imidazole). Fractions containing ArfA were pooled and dialyzed
against buffer C (buffer A without imidazole). The protein then was purified by ion-exchange chro-
matography (5 ml HiTrap FF Q-column, GE Healthcare; FPLC). The column was equilibrated and
washed with Buffer C, the protein was loaded in Buffer C and eluted with linear gradient of Buffer D
(Buffer C with 1 M KCl). Finally, the protein was dialyzed against 50 mM Tris-HCl buffer (pH 7.5), 150
mM KCl, 6 mM bME and protease inhibitor (complete Mini, EDTA-free protease inhibitor tablets,
Sigma Aldrich, USA) and purified using size-exclusion chromatography (Hiload 16/60 Superdex 75
pg column, GE Healthcare). The fractions of the protein were pulled, buffer exchanged (25 mM Tris-
HCl (pH 7.0), 50 mM K(CH3COO), 10 mM Mg(CH3COO)2, 10 mM NH4(CH3COO) and 6 mM bME)
and concentrated with an ultrafiltration unit using a 3 kDa cutoff membrane (Millipore). The concen-
trated protein was flash-frozen in liquid nitrogen and stored at  80˚C.
N-terminally His6-tagged RF2 (E. coli K12 strain) was purified as described (Korostelev et al.,
2008; Laurberg et al., 2008).
Preparation of the 70S rescue complex bound with ArfA.RF2
70S ribosomes were prepared from E. coli (MRE600) as described (Moazed and Noller, 1986,
1989), and stored in the ribosome-storage buffer (20 mM Tris-HCl (pH 7.0), 100 mM NH4Cl, 12.5
mM MgCl2, 0.5 mM EDTA, 6 mM bME) at  80˚C. Ribosomal 30S and 50S subunits were purified
using sucrose gradient (10–35%) in a ribosome-dissociation buffer (20 mM Tris-HCl (pH 7.0), 300 mM
NH4Cl, 1.5 mM MgCl2, 0.5 mM EDTA, 6 mM bME). The fractions containing 30S and 50S subunits
were collected separately, concentrated and stored in the ribosome-storage buffer at  80˚C. E. coli
tRNAfMet was purchased from Chemical Block. RNA, containing the Shine-Dalgarno sequence and a
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linker to place the AUG codon in the P site (GGC AAG GAG GUA AAA AUG) was synthesized by
IDT.
The 70S.mRNA.tRNAfMet.ArfA.RF2 complex was prepared by reconstitution in vitro. 2 mM 30S
subunit (all concentrations are specified for the final solution) were pre-activated at 42˚C for 5 min in
the ribosome-reconstitution buffer (20 mM Tris-HCl (pH 7.0), 100 mM NH4Cl, 20 mM MgCl2, 0.5 mM
EDTA, 6 mM bME). After pre-activation, 1.8 mM 50S subunit with 24 mM mRNA and 12 mM tRNAfMet
were added to the 30S solution and incubated for 15 min at 37˚C. ArfA and RF2 were then added at
16 mM each and the solution was incubated for 15 min at 37˚C and cooled down to room tempera-
ture. The solution was aliquoted, flash-frozen in liquid nitrogen and stored at  80˚C.
Activity of ArfA and RF2
Activity of ArfA and RF2 in the ArfA-mediated rescue was tested using [35S]-formylmethionine
release assay, essentially as we described previously (Svidritskiy et al., 2013). The pre-termination
complex was formed using E. coli 70S ribosomes, [35S]-labeled fMet-tRNAfMet (35S-labeled methio-
nine from Perkin Elmer) and truncated mRNA described above. Consistent with published data
(Chadani et al., 2012; Shimizu, 2012), neither ArfA nor RF2 alone induced release of [S35]-fMet
from the pre-termination complex. Similarly, a combination of ArfA and RF1 did not result in [S35]-
fMet release, consistent with the requirement for RF2. By contrast, efficient release was observed in
10 min after addition of ArfA and RF2 in combination, consistent with published data (Zeng and Jin,
2016). The time of the cryo-EM sample incubation prior to freezing (15 min, as described in the pre-
vious section) was therefore sufficient for achieving equilibrium and peptide release, suggesting that
the cryo-EM structures represent interconverting equilibrium states.
The release activity was tested as follows. 70S ribosome complex was formed by incubation of
0.7 mM (all concentrations are given for the final complex) of the 30S subunit at 42˚C for 5 min, fol-
lowed by addition of 0.7 mM of the 50S subunit, 3.5 mM truncated mRNA and incubation at 37˚C for
20 min (20 mM Tris acetate (pH 6.5), 100 mM ammonium acetate and 20 mM magnesium acetate).
The mixture was cooled to room temperature. 1 mM RF2, 10 mM ArfA and 150 nM [35S]-fMet-tRNAf-
Met were added to the solution to form the rescue complex (ArfA or RF2 were also tested separately
in independent experiments). 10 ml of the rescue complex were immediately quenched in 0.1 M HCl
to represent a zero-time point. 10 ml aliquots collected after 10 min and 1 hr were quenched in 30 ml
of 0.1 M HCl. [35S]-fMet-tRNAfMet was extracted with 700 ml of ethylacetate; 600 ml of the extract
were mixed with 3.5 ml of a scintillation cocktail (Econo-Safe). Samples were quantified using a scin-
tillation counter (Beckman).
Cryo-EM and image processing
Holey-carbon grids (C-flat 2/2) were exposed to a 75% argon/25% oxygen plasma for 20 s using a
Solarus 950 plasma cleaning system. The forward RF target was set to 7w. Before being applied to
the grids, the 70S.mRNA.tRNAfMet.ArfA.RF2 complex was diluted in the ribosome-reconstitution
buffer supplemented with ArfA and RF2 to the following final concentrations: ~0.45 mM 70S, 6 mM
mRNA, 3 mM tRNAfMet, 10 mM ArfA and 10 mM RF2. 2 ml of the 70S.mRNA.tRNAfMet.ArfA.RF2 com-
plex was applied to the grids. The grids were blotted for 5 s at blotting power 8 at 4˚C and ~95%
humidity and plunged into liquid ethane using an FEI Vitrobot MK4. The grids were stored in liquid
nitrogen.
A dataset of 539,311 particles was collected as follows. 3760 movies were collected using Legi-
non (Suloway et al., 2005) on an FEI Krios microscope operating at 300 kV equipped with a DE-20
Camera System (Direct Electron, LP, San Diego, CA) with  0.5 to  3.0 mm defocus. Each exposure
was acquired with continuous frame streaming at 32 frames per second (fps) with various exposure
lengths (38, 40, 54, 57 and 72 frames per movie) yielding a total dose of 61 e /A˚2. The nominal mag-
nification was 29,000 and the calibrated pixel size at the specimen level was 1.215 A˚. The frames for
each movie were processed using DE_process_frames script (in EMAN2 [Tang et al., 2007]) which is
available from Direct Electron at http://www.directelectron.com/scripts. The movies were motion-
corrected and frame averages were calculated using the first half of each movie (data up to a dose
of ~30 e /A˚2) and excluding the first two frames, after multiplication with the corresponding gain
reference. CTFFIND4 (Rohou and Grigorieff, 2015) was used to determine defocus values for each
resulting frame average. 503 movies with large drift, low signal, heavy ice contamination, or very thin
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ice were excluded from further analysis after inspection of the averages and the power spectra com-
puted by CTFFIND4. Particles were semi-automatically picked from full-sized images in EMAN2
using ~50 particles picked manually to serve as a reference. 320  320 pixel boxes with particles
were extracted from images and normalized. The stack and FREALIGN parameter file were assem-
bled in EMAN2. To speed up data processing, a 4x-binned image stack was prepared using
EMAN2.
Data classification is summarized in Figure 1—figure supplement 1. FREALIGN v9 (versions
9.10–9.11) was used for all steps of refinement and reconstruction (Grigorieff, 2016). The 4x-binned
image stack (539,311 particles) was initially aligned to a ribosome reference (PDB 4V4A) (Vila-
Sanjurjo et al., 2003) using 3 cycles of mode 4 (search and extend) alignment including data in the
resolution range from 300 A˚ to 30 A˚ until the convergence of the average score. Subsequently, the
4x binned stack was aligned against the common reference resulting from the previous step, using
mode 1 (refine) in the resolution ranges 300–18 A˚ and 300–12 A˚ (for both ranges, 3 cycles of mode
one were run). In the following steps, the 4x binned stack was replaced by the unbinned (full-resolu-
tion) image stack, which was successively aligned against the common reference using mode 1
(refine), including gradually increasing resolution limits (increments of 1 A˚, five cycles per each reso-
lution limit) up to 6 A˚. The resolution of the resulting common reference was 3.29 A˚ (Fourier Shell
Correlation (FSC) = 0.143). Subsequently, the refined parameters were used for classification of the
unbinned stack into 10 classes in 30 cycles using the resolution range of 300–6 A˚. This classification
revealed seven high-resolution classes and three low-resolution (junk) classes (Figure 1—figure sup-
plement 1). The particles assigned to the high-resolution classes that contained RF2 and ArfA were
extracted from the unbinned stack (with >50% occupancy and scores >0) using merge_classes.exe
(part of the FREALIGN distribution), resulting in a stack containing 320,895 particles. Classification
of this stack was performed for 30 cycles using a focused spherical mask around the A site (55 A˚
radius, as implemented in FREALIGN). This classification yielded three high-resolution classes, two of
which contained both ArfA and RF2 (Structures I and II) and one with a vacant mRNA tunnel and A
site. Using more classes (up to 8) did not yield additional structures (e.g. containing ArfA alone, RF2
alone or additional ArfA.RF2 conformations). For the classes of interest (Structures I and II), particles
with >50% occupancy and scores >0 were extracted from the unbinned stack. Refinement to 6 A˚ res-
olution using mode 1 (five cycles) resulted in ~3.15 A˚ maps (FSC = 0.143). The maps were sharpened
using automatically calculated B-factors (approximately  90 A˚2) in bfactor.exe (part of the FREA-
LIGN distribution) and used for model building and structure refinements. B-factors of  120 or
 150 A˚2 were also used to interpret high-resolution details in the ribosome core regions. FSC curves
were calculated by FREALIGN for even and odd particle half-sets.
Following the submission of our manuscript, several groups reported 70S.ArfA.RF2 cryo-EM
structures (James et al., 2016; Huter et al., 2017; Ma et al., 2017; Zeng et al., 2017), but each
dataset contained a single ArfA.RF2 conformation (similar to our Structure I and Structure II), unlike
our dataset, which contained both ArfA.RF2 states. We hypothesize that this difference may be due
to several factors. First, different dataset sizes and processing strategies may have influenced the
identification of particle classes. Most notably, we use FREALIGN in all our work for particle align-
ment and classification, consistently yielding multiple states (Svidritskiy et al., 2014; Koh et al.,
2014; Abeyrathne et al., 2016; Loveland et al., 2016). In some cases, this contrasted the results
from other groups that reported only single states. Most recently, we reported several globally dif-
ferent 70S.RelA states from a single sample (Loveland et al., 2016) while work on similar (but not
identical) 70S.RelA complexes using different data processing approaches yielded only a single state
(Arenz et al., 2016; Brown et al., 2016). However, clarification of the role of FREALIGN in our con-
sistent discovery of multiple structures requires further testing, including reprocessing of datasets
from different groups with different software. Second, different buffer conditions, strategies of com-
plex formation (e.g. the use of individual ribosomal subunits in our work) and constructs (e.g. ribo-
some, RF2 or ArfA strains) may have led to different equilibria between Structure I and Structure II.
The presence of the His6-tag on ArfA in our work may have led to stabilization of Structure I. In the
absence of density for His6 in our maps, however, we cannot explain how it may have stabilized the
structure.
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Model building and refinement
Recently reported cryo-EM structure of E. coli 70S.RelA.A/R-tRNAPhe complex (Loveland et al.,
2016), excluding RelA and tRNAPhe, was used as a starting model for structure refinement. The
structure of compact RF2 (Structure I) was built using the crystal structure of free RF2 (PDB 1GQE)
(Vestergaard et al., 2001) as a starting model. The extended form of RF2 (Structure II) was created
by homology modeling from Thermus thermophilus RF2 within a 70S termination complex
(Korostelev et al., 2008) using SWISS-PROT (Bairoch et al., 2004). ArfA was modeled de novo in
Coot (RRID:SCR_014222) (Emsley and Cowtan, 2004), using an initial structure predicted by
ROBETTA (Kim et al., 2004). The secondary structure in our resulting model of AfrA is consistent
with those predicted by ROBETTA and I-TASSER (RRID:SCR_014627) (Yang et al., 2015). Initial pro-
tein and ribosome domain fitting into cryo-EM maps was performed using Chimera (RRID:SCR_
004097) (Pettersen et al., 2004), followed by manual modeling using Pymol (RRID:SCR_000305)
(DeLano, 2002) and Coot. The linkers between the domains and parts of the domains that were not
well defined in the cryo-EM maps (e.g. loops of RF2 in Structure I, shown in Figure 1—figure sup-
plement 4A) were modeled as protein or RNA backbone.
Structures I and II were refined by real-space simulated-annealing refinement using atomic elec-
tron scattering factors (Gonen et al., 2005) in RSRef (Chapman, 1995; Korostelev et al., 2002) as
described (Svidritskiy et al., 2014). Secondary-structure restraints, comprising hydrogen-bonding
restraints for ribosomal proteins and base-pairing restraints for RNA molecules, were employed as
described (Korostelev et al., 2008). Refinement parameters, such as the relative weighting of ste-
reochemical restraints and experimental energy term, were optimized to produce the stereochemi-
cally optimal models that closely agree with the corresponding maps. In the final stage, the
structures were refined using phenix.real_space_refine (RRID:SCR_014224) (Adams et al., 2010), fol-
lowed by a round of refinement in RSRef applying harmonic restraints to preserve protein backbone
geometry. Ions were modeled as Mg2+, filling the difference-map peaks using CNS (Brunger, 2007).
To this end, the maps were converted to structure factors using phenix.map_to_structure_factors
(Adams et al., 2010). The refined structural models closely agree with the corresponding maps, as
indicated by high correlation coefficients of >0.8 and low real-space R-factors of 0.19 for Structures I
and II. The resulting models have excellent stereochemical parameters, characterized by low devia-
tion from ideal bond lengths and angles, low number of protein-backbone outliers (no outliers in
ArfA) and other robust structure-quality statistics, as shown in Table 1. Structure quality was vali-
dated using MolProbity (RRID:SCR_014226) (Chen et al., 2010).
Structure superpositions and distance calculations were performed in Pymol. The cryo-EM maps
for Structure I and II were deposited in the EMDB (EMD-8522 and EMD-8521, respectively) (RRID:
SCR_006506). PDB coordinates for Structures I and II were deposited in the RCSB (PDB codes 5U9G
and 5U9F, respectively) (RRID:SCR_012820). Figures were prepared in Pymol and Chimera
(DeLano, 2002; Pettersen et al., 2004).
Sequence and structural analysis
NCBI (PSI) BLAST (RRID:SCR_004870) (Altschul et al., 1997) was used to obtain ~400 non-redundant
ArfA homolog sequences with less than 95% identity to that of E. coli ArfA. MUSCLE (RRID:SCR_
011812) (Edgar, 2004) was used to generate a multiple-sequence alignment which was presented
with WebLogo 3 (RRID:SCR_010236) (Crooks et al., 2004) (Figure 2).
Acknowledgements
We thank the National Institute of Genetics, Shizouka, Japan for providing ArfA- and RF2-overex-
pressing strains of E. coli (ASKA- library); Yevheniya Stepanyuk for assistance with ArfA subcloning;
Michael Spilman (Direct Electron, LP) for assistance with data collection and processing; Anna B
Loveland for assistance with data processing; Darryl Conte Jr for assistance with manuscript prepara-
tion; members of the Korostelev laboratory for helpful discussions and comments on the manuscript.
This study was supported by NIH Grants R01 GM106105 and GM107465 (to AAK). All authors con-
tributed to manuscript finalization in the acknowledgements section
Demo et al. eLife 2017;6:e23687. DOI: 10.7554/eLife.23687 14 of 18
Research article Biochemistry Biophysics and Structural Biology
Additional information
Competing interests
NG: Reviewing editor, eLife. The other authors declare that no competing interests exist.
Funding
Funder Grant reference number Author
National Institutes of Health GM106105 Andrei A Korostelev
National Institutes of Health GM107465 Andrei A Korostelev
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
GD, Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualiza-
tion, Methodology, Writing—original draft, Project administration, Writing—review and editing,
Conceived and designed the project, Prepared the ribosome complex and processed cryo-EM data,
Built structural models and wrote the manuscript, Tested ArfA and RF2 in peptide release assays,
Contributed to manuscript finalization; ES, Formal analysis, Assisted with protein and ribosome puri-
fication, Tested ArfA and RF2 in peptide release assays, Contributed to manuscript finalization; RM,
Formal analysis, Assisted with protein and ribosome purification, Contributed to manuscript finaliza-
tion; RD-A, TG, NG, Data curation, Software, Formal analysis, Methodology, Assisted with cryo-EM
data collection and processing of preliminary datasets, Contributed to manuscript finalization; DS,
Data curation, Software, Formal analysis, Methodology, Assisted with cryo-EM sample preparation,
Collected cryo-EM data and assisted with initial data processing, Contributed to manuscript finaliza-
tion; AAK, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Val-
idation, Investigation, Visualization, Methodology, Writing—original draft, Project administration,
Writing—review and editing, Conceived and designed the project, Built structural models and wrote





Andrei A Korostelev, http://orcid.org/0000-0003-1588-717X
Additional files
Major datasets
The following datasets were generated:








N, Sousa D, Kor-
ostelev AA
2017 3.2 A cryo-EM ArfA-RF2 ribosome












N, Sousa D, Kor-
ostelev AA
2017 3.2 A cryo-EM ArfA-RF2 ribosome










2017 3.2 A cryo-EM ArfA-RF2 ribosome





Demo et al. eLife 2017;6:e23687. DOI: 10.7554/eLife.23687 15 of 18
Research article Biochemistry Biophysics and Structural Biology
Diaz-Avalos R,
Grant T, Grigorieff
N, Sousa D, Kor-
ostelev AA






N, Sousa D, Kor-
ostelev AA
2017 3.2 A cryo-EM ArfA-RF2 ribosome









Abeyrathne PD, Koh CS, Grant T, Grigorieff N, Korostelev AA. 2016. Ensemble cryo-EM uncovers inchworm-like
translocation of a viral IRES through the ribosome. eLife 5:e14874. doi: 10.7554/eLife.14874, PMID: 27159452
Adams PD, Afonine PV, Bunko´czi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-
Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC,
Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta
Crystallographica Section D Biological Crystallography 66:213–221. doi: 10.1107/S0907444909052925,
PMID: 20124702
Altschul SF, Madden TL, Scha¨ffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-
BLAST: a new generation of protein database search programs. Nucleic Acids Research 25:3389–3402. doi: 10.
1093/nar/25.17.3389, PMID: 9254694
Arenz S, Abdelshahid M, Sohmen D, Payoe R, Starosta AL, Berninghausen O, Hauryliuk V, Beckmann R, Wilson
DN. 2016. The stringent factor RelA adopts an open conformation on the ribosome to stimulate ppGpp
synthesis. Nucleic Acids Research 44:6471–6481. doi: 10.1093/nar/gkw470, PMID: 27226493
Bairoch A, Boeckmann B, Ferro S, Gasteiger E. 2004. Swiss-Prot: juggling between evolution and stability.
Briefings in Bioinformatics 5:39–55. doi: 10.1093/bib/5.1.39, PMID: 15153305
Brown A, Ferna´ndez IS, Gordiyenko Y, Ramakrishnan V. 2016. Ribosome-dependent activation of stringent
control. Nature 534:277–280. doi: 10.1038/nature17675, PMID: 27279228
Brunger AT. 2007. Version 1.2 of the crystallography and NMR system. Nature Protocols 2:2728–2733. doi: 10.
1038/nprot.2007.406, PMID: 18007608
Chadani Y, Ono K, Ozawa S, Takahashi Y, Takai K, Nanamiya H, Tozawa Y, Kutsukake K, Abo T. 2010. Ribosome
rescue by Escherichia coli ArfA (YhdL) in the absence of trans-translation system. Molecular Microbiology 78:
796–808. doi: 10.1111/j.1365-2958.2010.07375.x, PMID: 21062370
Chadani Y, Matsumoto E, Aso H, Wada T, Kutsukake K, Sutou S, Abo T. 2011. trans-translation-mediated tight
regulation of the expression of the alternative ribosome-rescue factor ArfA in Escherichia coli. Genes & Genetic
Systems 86:151–163. doi: 10.1266/ggs.86.151, PMID: 21952205
Chadani Y, Ito K, Kutsukake K, Abo T. 2012. ArfA recruits release factor 2 to rescue stalled ribosomes by
peptidyl-tRNA hydrolysis in Escherichia coli. Molecular Microbiology 86:37–50. doi: 10.1111/j.1365-2958.2012.
08190.x, PMID: 22857598
Chapman MS. 1995. Restrained real-space macromolecular atomic refinement using a new resolution-dependent
electron-density function. Acta Crystallographica Section a Foundations of Crystallography 51:69–80. doi: 10.
1107/S0108767394007130
Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson
DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallographica
Section D Biological Crystallography 66:12–21. doi: 10.1107/S0907444909042073, PMID: 20057044
Craigen WJ, Caskey CT. 1987. The function, structure and regulation of E. coli peptide chain release factors.
Biochimie 69:1031–1041. doi: 10.1016/0300-9084(87)90003-4, PMID: 3126822
Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Research
14:1188–1190. doi: 10.1101/gr.849004, PMID: 15173120
DeLano WL. 2002. The PyMOL molecular graphics system. In: The PyMOL Molecular Graphics System. Palo
Alto, CA, USA: DeLano Scientific.
Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids
Research 32:1792–1797. doi: 10.1093/nar/gkh340, PMID: 15034147
Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallographica Section D
Biological Crystallography 60:2126–2132. doi: 10.1107/S0907444904019158, PMID: 15572765
Freistroffer DV, Kwiatkowski M, Buckingham RH, Ehrenberg M. 2000. The accuracy of codon recognition by
polypeptide release factors. PNAS 97:2046–2051. doi: 10.1073/pnas.030541097, PMID: 10681447
Gagnon MG, Seetharaman SV, Bulkley D, Steitz TA. 2012. Structural basis for the rescue of stalled ribosomes:
structure of YaeJ bound to the ribosome. Science 335:1370–1372. doi: 10.1126/science.1217443, PMID: 22422
986
Garza-Sa´nchez F, Schaub RE, Janssen BD, Hayes CS. 2011. tmRNA regulates synthesis of the ArfA ribosome
rescue factor. Molecular Microbiology 80:1204–1219. doi: 10.1111/j.1365-2958.2011.07638.x, PMID: 21435036
Gonen T, Cheng Y, Sliz P, Hiroaki Y, Fujiyoshi Y, Harrison SC, Walz T. 2005. Lipid-protein interactions in double-
layered two-dimensional AQP0 crystals. Nature 438:633–638. doi: 10.1038/nature04321, PMID: 16319884
Demo et al. eLife 2017;6:e23687. DOI: 10.7554/eLife.23687 16 of 18
Research article Biochemistry Biophysics and Structural Biology
Grigorieff N. 2016. Frealign: an exploratory tool for Single-Particle Cryo-EM. Methods in Enzymology 579:191–
226. doi: 10.1016/bs.mie.2016.04.013, PMID: 27572728
Handa Y, Inaho N, Nameki N. 2011. YaeJ is a novel ribosome-associated protein in Escherichia coli that can
hydrolyze peptidyl-tRNA on stalled ribosomes. Nucleic Acids Research 39:1739–1748. doi: 10.1093/nar/
gkq1097, PMID: 21051357
Hayes CS, Keiler KC. 2010. Beyond ribosome rescue: tmrna and co-translational processes. FEBS Letters 584:
413–419. doi: 10.1016/j.febslet.2009.11.023, PMID: 19914241
He SL, Green R. 2010. Visualization of codon-dependent conformational rearrangements during translation
termination. Nature Structural & Molecular Biology 17:465–470. doi: 10.1038/nsmb.1766, PMID: 20208546
Huter P, Mu¨ller C, Beckert B, Arenz S, Berninghausen O, Beckmann R, Wilson DN. 2017. Structural basis for
ArfA-RF2-mediated translation termination on mRNAs lacking stop codons. Nature 541:546–549. doi: 10.1038/
nature20821, PMID: 27906161
Ito K, Chadani Y, Nakamori K, Chiba S, Akiyama Y, Abo T. 2011. Nascentome analysis uncovers futile protein
synthesis in Escherichia coli. PLoS One 6:e28413. doi: 10.1371/journal.pone.0028413, PMID: 22162769
Ivanova N, Pavlov MY, Felden B, Ehrenberg M. 2004. Ribosome rescue by tmRNA requires truncated mRNAs.
Journal of Molecular Biology 338:33–41. doi: 10.1016/j.jmb.2004.02.043, PMID: 15050821
James NR, Brown A, Gordiyenko Y, Ramakrishnan V. 2016. Translational termination without a stop codon.
Science 354:1437–1440. doi: 10.1126/science.aai9127, PMID: 27934701
Keiler KC. 2015. Mechanisms of ribosome rescue in bacteria. Nature Reviews Microbiology 13:285–297. doi: 10.
1038/nrmicro3438, PMID: 25874843
Kim DE, Chivian D, Baker D. 2004. Protein structure prediction and analysis using the robetta server. Nucleic
Acids Research 32:W526–W531. doi: 10.1093/nar/gkh468, PMID: 15215442
Koh CS, Brilot AF, Grigorieff N, Korostelev AA. 2014. Taura syndrome virus IRES initiates translation by binding
its tRNA-mRNA-like structural element in the ribosomal decoding center. PNAS 111:9139–9144. doi: 10.1073/
pnas.1406335111, PMID: 24927574
Korostelev A, Bertram R, Chapman MS. 2002. Simulated-annealing real-space refinement as a tool in model
building. Acta Crystallographica Section D Biological Crystallography 58:761–767. doi: 10.1107/
S0907444902003402, PMID: 11976486
Korostelev A, Trakhanov S, Laurberg M, Noller HF. 2006. Crystal structure of a 70S ribosome-tRNA complex
reveals functional interactions and rearrangements. Cell 126:1065–1077. doi: 10.1016/j.cell.2006.08.032,
PMID: 16962654
Korostelev A, Asahara H, Lancaster L, Laurberg M, Hirschi A, Zhu J, Trakhanov S, Scott WG, Noller HF. 2008.
Crystal structure of a translation termination complex formed with release factor RF2. PNAS 105:19684–19689.
doi: 10.1073/pnas.0810953105, PMID: 19064930
Korostelev A, Zhu J, Asahara H, Noller HF. 2010. Recognition of the amber UAG stop codon by release factor
RF1. The EMBO Journal 29:2577–2585. doi: 10.1038/emboj.2010.139, PMID: 20588254
Korostelev AA. 2011. Structural aspects of translation termination on the ribosome. Rna 17:1409–1421. doi: 10.
1261/rna.2733411, PMID: 21700725
Kurita D, Chadani Y, Muto A, Abo T, Himeno H. 2014. ArfA recognizes the lack of mRNA in the mRNA channel
after RF2 binding for ribosome rescue. Nucleic Acids Research 42:13339–13352. doi: 10.1093/nar/gku1069,
PMID: 25355516
Laurberg M, Asahara H, Korostelev A, Zhu J, Trakhanov S, Noller HF. 2008. Structural basis for translation
termination on the 70S ribosome. Nature 454:852–857. doi: 10.1038/nature07115, PMID: 18596689
Loveland AB, Bah E, Madireddy R, Zhang Y, Brilot AF, Grigorieff N, Korostelev AA . 2016. Ribosome.RelA
structures reveal the mechanism of stringent response activation. eLife 5:e17029. doi: 10.7554/eLife.17029,
PMID: 27434674
Ma C, Kurita D, Li N, Chen Y, Himeno H, Gao N. 2017. Mechanistic insights into the alternative translation
termination by ArfA and RF2. Nature 541:550–553. doi: 10.1038/nature20822, PMID: 27906160
Moazed D, Noller HF. 1986. Transfer RNA shields specific nucleotides in 16S ribosomal RNA from attack by
chemical probes. Cell 47:985–994. doi: 10.1016/0092-8674(86)90813-5, PMID: 2430725
Moazed D, Noller HF. 1989. Interaction of tRNA with 23S rRNA in the ribosomal A, P, and E sites. Cell 57:585–
597. doi: 10.1016/0092-8674(89)90128-1, PMID: 2470511
Neubauer C, Gillet R, Kelley AC, Ramakrishnan V. 2012. Decoding in the absence of a codon by tmRNA and
SmpB in the ribosome. Science 335:1366–1369. doi: 10.1126/science.1217039, PMID: 22422985
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF chimera–a
visualization system for exploratory research and analysis. Journal of Computational Chemistry 25:1605–1612.
doi: 10.1002/jcc.20084, PMID: 15264254
Ramrath DJ, Yamamoto H, Rother K, Wittek D, Pech M, Mielke T, Loerke J, Scheerer P, Ivanov P, Teraoka Y,
Shpanchenko O, Nierhaus KH, Spahn CM. 2012. The complex of tmRNA-SmpB and EF-G on translocating
ribosomes. Nature 485:526–529. doi: 10.1038/nature11006, PMID: 22622583
Rawat UB, Zavialov AV, Sengupta J, Valle M, Grassucci RA, Linde J, Vestergaard B, Ehrenberg M, Frank J. 2003.
A cryo-electron microscopic study of ribosome-bound termination factor RF2. Nature 421:87–90. doi: 10.1038/
nature01224, PMID: 12511960
Rohou A, Grigorieff N. 2015. CTFFIND4: fast and accurate defocus estimation from electron micrographs.
Journal of Structural Biology 192:216–221. doi: 10.1016/j.jsb.2015.08.008, PMID: 26278980
Demo et al. eLife 2017;6:e23687. DOI: 10.7554/eLife.23687 17 of 18
Research article Biochemistry Biophysics and Structural Biology
Santos N, Zhu J, Donohue JP, Korostelev AA, Noller HF. 2013. Crystal structure of the 70S ribosome bound with
the Q253P mutant form of release factor RF2. Structure 21:1258–1263. doi: 10.1016/j.str.2013.04.028,
PMID: 23769667
Sato H, Ito K, Nakamura Y. 2006. Ribosomal protein L11 mutations in two functional domains equally affect
release factors 1 and 2 activity. Molecular Microbiology 60:108–120. doi: 10.1111/j.1365-2958.2006.05094.x,
PMID: 16556224
Schaub RE, Poole SJ, Garza-Sa´nchez F, Benbow S, Hayes CS. 2012. Proteobacterial ArfA peptides are
synthesized from non-stop messenger RNAs. Journal of Biological Chemistry 287:29765–29775. doi: 10.1074/
jbc.M112.374074, PMID: 22791716
Selmer M, Dunham CM, Murphy FV, Weixlbaumer A, Petry S, Kelley AC, Weir JR, Ramakrishnan V. 2006.
Structure of the 70S ribosome complexed with mRNA and tRNA. Science 313:1935–1942. doi: 10.1126/
science.1131127, PMID: 16959973
Shimizu Y. 2012. ArfA recruits RF2 into stalled ribosomes. Journal of Molecular Biology 423:624–631. doi: 10.
1016/j.jmb.2012.08.007, PMID: 22922063
Shin DH, Brandsen J, Jancarik J, Yokota H, Kim R, Kim SH. 2004. Structural analyses of peptide release factor 1
from thermotoga maritima reveal domain flexibility required for its interaction with the ribosome. Journal of
Molecular Biology 341:227–239. doi: 10.1016/j.jmb.2004.05.055, PMID: 15312775
Suloway C, Pulokas J, Fellmann D, Cheng A, Guerra F, Quispe J, Stagg S, Potter CS, Carragher B. 2005.
Automated molecular microscopy: the new leginon system. Journal of Structural Biology 151:41–60. doi: 10.
1016/j.jsb.2005.03.010, PMID: 15890530
Svidritskiy E, Ling C, Ermolenko DN, Korostelev AA. 2013. Blasticidin S inhibits translation by trapping deformed
tRNA on the ribosome. PNAS 110:12283–12288. doi: 10.1073/pnas.1304922110, PMID: 23824292
Svidritskiy E, Brilot AF, Koh CS, Grigorieff N, Korostelev AA. 2014. Structures of yeast 80S ribosome-tRNA
complexes in the rotated and nonrotated conformations. Structure 22:1210–1218. doi: 10.1016/j.str.2014.06.
003, PMID: 25043550
Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ. 2007. EMAN2: an extensible image
processing suite for electron microscopy. Journal of Structural Biology 157:38–46. doi: 10.1016/j.jsb.2006.05.
009, PMID: 16859925
Trappl K, Joseph S. 2016. Ribosome induces a closed to open conformational change in release factor 1. Journal
of Molecular Biology 428:1333–1344. doi: 10.1016/j.jmb.2016.01.021, PMID: 26827724
Vestergaard B, Van LB, Andersen GR, Nyborg J, Buckingham RH, Kjeldgaard M. 2001. Bacterial polypeptide
release factor RF2 is structurally distinct from eukaryotic eRF1. Molecular Cell 8:1375–1382. doi: 10.1016/
S1097-2765(01)00415-4, PMID: 11779511
Vestergaard B, Sanyal S, Roessle M, Mora L, Buckingham RH, Kastrup JS, Gajhede M, Svergun DI, Ehrenberg M.
2005. The SAXS solution structure of RF1 differs from its crystal structure and is similar to its ribosome bound
cryo-EM structure. Molecular Cell 20:929–938. doi: 10.1016/j.molcel.2005.11.022, PMID: 16364917
Vila-Sanjurjo A, Ridgeway WK, Seymaner V, Zhang W, Santoso S, Yu K, Cate JH. 2003. X-ray crystal structures of
the WT and a hyper-accurate ribosome from Escherichia coli. PNAS 100:8682–8687. doi: 10.1073/pnas.
1133380100, PMID: 12853578
Weixlbaumer A, Jin H, Neubauer C, Voorhees RM, Petry S, Kelley AC, Ramakrishnan V. 2008. Insights into
translational termination from the structure of RF2 bound to the ribosome. Science 322:953–956. doi: 10.1126/
science.1164840, PMID: 18988853
Xu W, Pagel FT, Murgola EJ. 2002. Mutations in the GTPase center of Escherichia coli 23S rRNA indicate release
factor 2-interactive sites. Journal of Bacteriology 184:1200–1203. doi: 10.1128/jb.184.4.1200-1203.2002,
PMID: 11807083
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. 2015. The I-TASSER suite: protein structure and function
prediction. Nature Methods 12:7–8. doi: 10.1038/nmeth.3213, PMID: 25549265
Yusupov MM, Yusupova GZ, Baucom A, Lieberman K, Earnest TN, Cate JH, Noller HF. 2001. Crystal structure of
the ribosome at 5.5 A resolution. Science 292:883–896. doi: 10.1126/science.1060089, PMID: 11283358
Zeng F, Jin H. 2016. Peptide release promoted by methylated RF2 and ArfA in nonstop translation is achieved by
an induced-fit mechanism. Rna 22:49–60. doi: 10.1261/rna.053082.115, PMID: 26554029
Zeng F, Chen Y, Remis J, Shekhar M, Phillips JC, Tajkhorshid E, Jin H. 2017. Structural basis of co-translational
quality control by ArfA and RF2 bound to ribosome. Nature 541:554–557. doi: 10.1038/nature21053, PMID: 2
8077875
Zolda´k G, Redecke L, Svergun DI, Konarev PV, Voertler CS, Dobbek H, Sedla´k E, Sprinzl M. 2007. Release factors
2 from Escherichia coli and thermus thermophilus: structural, spectroscopic and microcalorimetric studies.
Nucleic Acids Research 35:1343–1353. doi: 10.1093/nar/gkl696, PMID: 17272297
Demo et al. eLife 2017;6:e23687. DOI: 10.7554/eLife.23687 18 of 18
Research article Biochemistry Biophysics and Structural Biology
